Microbio Co Ltd
Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia in women before menopause and relieved dysmenorrhea. It also involved in the trading of organic foods; sale of beverages; pr… Read more
Microbio Co Ltd (4128) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.005x
Based on the latest financial reports, Microbio Co Ltd (4128) has a cash flow conversion efficiency ratio of 0.005x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$51.95 Million) by net assets (NT$10.40 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Microbio Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Microbio Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Microbio Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Microbio Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Avia Avian PT Tbk
JK:AVIA
|
0.062x |
|
XinJiang GuoTong Pipeline Co Ltd
SHE:002205
|
-0.087x |
|
Odfjell SE
OL:ODF
|
0.313x |
|
Shanghai Weihong Electronic Technology Co Ltd
SHE:300508
|
0.035x |
|
Senvest Capital Inc
PINK:SVCTF
|
0.009x |
|
MCNEX Co. Ltd
KQ:097520
|
0.085x |
|
Sumber Tani Agung Resources Tbk PT
JK:STAA
|
0.115x |
|
Funding Circle Holdings plc
PINK:FDCHF
|
0.003x |
Annual Cash Flow Conversion Efficiency for Microbio Co Ltd (2006–2024)
The table below shows the annual cash flow conversion efficiency of Microbio Co Ltd from 2006 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$11.87 Billion | NT$529.90 Million | 0.045x | +871.28% |
| 2023-12-31 | NT$13.50 Billion | NT$-78.15 Million | -0.006x | -157.28% |
| 2022-12-31 | NT$14.01 Billion | NT$141.57 Million | 0.010x | +159.17% |
| 2021-12-31 | NT$13.84 Billion | NT$53.98 Million | 0.004x | -54.37% |
| 2020-12-31 | NT$12.85 Billion | NT$109.82 Million | 0.009x | +6.78% |
| 2019-12-31 | NT$9.04 Billion | NT$72.36 Million | 0.008x | +388.65% |
| 2018-12-31 | NT$9.68 Billion | NT$15.85 Million | 0.002x | +238.29% |
| 2017-12-31 | NT$8.30 Billion | NT$-9.83 Million | -0.001x | +94.47% |
| 2016-12-31 | NT$8.41 Billion | NT$-180.25 Million | -0.021x | -18.36% |
| 2015-12-31 | NT$8.94 Billion | NT$-161.90 Million | -0.018x | +1.39% |
| 2014-12-31 | NT$9.10 Billion | NT$-167.04 Million | -0.018x | +9.53% |
| 2013-12-31 | NT$8.70 Billion | NT$-176.63 Million | -0.020x | +3.13% |
| 2012-12-31 | NT$6.32 Billion | NT$-132.36 Million | -0.021x | +51.99% |
| 2011-12-31 | NT$6.23 Billion | NT$-271.95 Million | -0.044x | -142.24% |
| 2010-12-31 | NT$5.04 Billion | NT$520.41 Million | 0.103x | +211.97% |
| 2009-12-31 | NT$5.26 Billion | NT$-485.10 Million | -0.092x | -15.56% |
| 2008-12-31 | NT$1.79 Billion | NT$-143.21 Million | -0.080x | -8.41% |
| 2007-12-31 | NT$1.29 Billion | NT$-95.30 Million | -0.074x | -1038.56% |
| 2006-12-31 | NT$559.40 Million | NT$4.39 Million | 0.008x | -- |